{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T13:22:45Z","timestamp":1788614565990,"version":"build-2803163510"},"reference-count":101,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100012264","name":"NIH","doi-asserted-by":"publisher","award":["CA182413"],"award-info":[{"award-number":["CA182413"]}],"id":[{"id":"10.13039\/501100012264","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012264","name":"NIH","doi-asserted-by":"publisher","award":["CA260115"],"award-info":[{"award-number":["CA260115"]}],"id":[{"id":"10.13039\/501100012264","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012264","name":"NIH","doi-asserted-by":"publisher","award":["CA248524"],"award-info":[{"award-number":["CA248524"]}],"id":[{"id":"10.13039\/501100012264","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001282","name":"Ovarian Cancer Research","doi-asserted-by":"publisher","award":["327516"],"award-info":[{"award-number":["327516"]}],"id":[{"id":"10.13039\/100001282","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sandra Atlas Bass Endowment for Cancer Research"},{"name":"Graduate Research Fellowship Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>High-grade serous ovarian carcinoma (HGSC) is the sixth leading cause of cancer-related death among women. Most tumors arise from the Fallopian tubal epithelium (TE), exhibit numerous mutations, and present heterogenous pathological features. However, the contribution of specific mutation combinations to cellular transformation, pathological phenotype, and chemotherapeutic responses remains unclear. We used a mouse TE organoid platform for combinatorial CRISPR mutagenesis of 20 candidate HGSC driver genes. Besides Trp53, mutations in Nf1, Cdkn2a, and Map2k4 were the most prevalent in phenotypically transformed organoids. Map2k4 mutant organoids transplanted into mice predominantly yielded papillary-glandular carcinomas, whereas those with Nf1 mutations were more mesenchymal-like. Map2k4 mutant cells were particularly sensitive to paclitaxel, and Rho kinase inhibitor (ROCKi) increased trametinib sensitivity in both Map2k4- and Nf1-mutant organoids. This organoid mutagenesis strategy is powerful for unraveling the genetic and phenotypic complexity of HGSC, and identified Map2k4 as a potential therapeutic target in select HGSC cases.<\/jats:p>","DOI":"10.1093\/genetics\/iyag098","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T03:29:12Z","timestamp":1776310152000},"source":"Crossref","is-referenced-by-count":1,"title":["Multiplex organoid mutagenesis reveals gene combinations driving transformation, pathology, and chemosensitivity in ovarian carcinoma"],"prefix":"10.1093","volume":"233","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4049-8694","authenticated-orcid":false,"given":"Daryl J","family":"Phuong","sequence":"first","affiliation":[{"name":"Department of Biomedical and Translational Sciences, Cornell University, College of Veterinary Medicine , 618 Tower Rd, Ithaca, NY 14853 ,","place":["United States"]},{"name":"Department of Molecular Biology and Genetics, Cornell University, College of Agriculture and Life Sciences , Ithaca, NY 14853 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2093-6482","authenticated-orcid":false,"given":"Coulter Q","family":"Ralston","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Translational Sciences, Cornell University, College of Veterinary Medicine , 618 Tower Rd, Ithaca, NY 14853 ,","place":["United States"]},{"name":"Meinig School of Biomedical Engineering, Cornell University , Ithaca, NY 14853 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony M","family":"Ezzat","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Translational Sciences, Cornell University, College of Veterinary Medicine , 618 Tower Rd, Ithaca, NY 14853 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S","family":"Ashe","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Translational Sciences, Cornell University, College of Veterinary Medicine , 618 Tower Rd, Ithaca, NY 14853 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda P","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Translational Sciences, Cornell University, College of Veterinary Medicine , 618 Tower Rd, Ithaca, NY 14853 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3017-1399","authenticated-orcid":false,"given":"Andrea","family":"Flesken-Nikitin","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Translational Sciences, Cornell University, College of Veterinary Medicine , 618 Tower Rd, Ithaca, NY 14853 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Yamulla","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Translational Sciences, Cornell University, College of Veterinary Medicine , 618 Tower Rd, Ithaca, NY 14853 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Yu","family":"Nikitin","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Translational Sciences, Cornell University, College of Veterinary Medicine , 618 Tower Rd, Ithaca, NY 14853 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7294-1876","authenticated-orcid":false,"given":"John C","family":"Schimenti","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Translational Sciences, Cornell University, College of Veterinary Medicine , 618 Tower Rd, Ithaca, NY 14853 ,","place":["United States"]},{"name":"Department of Molecular Biology and Genetics, Cornell University, College of Agriculture and Life Sciences , Ithaca, NY 14853 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"2026060319584668400_iyag098-B1","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"2026060319584668400_iyag098-B2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/0092-8674(90)90151-4","article-title":"The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins","volume":"63","author":"Ballester","year":"1990","journal-title":"Cell"},{"key":"2026060319584668400_iyag098-B3","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.trecan.2022.12.001","article-title":"Preclinical to clinical utility of ROCK inhibitors in cancer","volume":"9","author":"Barcelo","year":"2023","journal-title":"Trends Cancer"},{"key":"2026060319584668400_iyag098-B4","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1038\/s41467-024-46531-1","article-title":"Expected and unexpected effects after systemic inhibition of hippo transcriptional output in cancer","volume":"15","author":"Baroja","year":"2024","journal-title":"Nat Commun"},{"key":"2026060319584668400_iyag098-B5","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1002\/neu.20327","article-title":"ERK\/MAPK pathway regulates GABAA receptors","volume":"66","author":"Bell-Horner","year":"2006","journal-title":"J Neurobiol"},{"key":"2026060319584668400_iyag098-B6","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer","volume":"15","author":"Bowtell","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"2026060319584668400_iyag098-B7","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Cancer Genome Atlas Research Network","year":"2011","journal-title":"Nature"},{"key":"2026060319584668400_iyag098-B8","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41580-020-00322-w","article-title":"Diversity and versatility of p38 kinase signalling in health and disease","volume":"22","author":"Canovas","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2026060319584668400_iyag098-B9","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.1158\/1078-0432.CCR-18-0784","article-title":"Consensus on molecular subtypes of high-grade serous ovarian carcinoma","volume":"24","author":"Chen","year":"2018","journal-title":"Clin Cancer Res"},{"key":"2026060319584668400_iyag098-B10","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.1002\/cam4.4752","article-title":"Better or worse? The prognostic role of the mesenchymal subtype in patients with high-grade serous ovarian carcinoma: a systematic review and meta-analysis","volume":"11","author":"Chen","year":"2022","journal-title":"Cancer Med"},{"key":"2026060319584668400_iyag098-B11","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.921146","article-title":"Incidental serous tubal intraepithelial carcinoma that developed into primary peritoneal serous carcinoma in a patient without BRCA mutation","volume":"21","author":"Chong","year":"2020","journal-title":"Am J Case Rep"},{"key":"2026060319584668400_iyag098-B12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/1471-2407-11-173","article-title":"Analysis of the mitogen-activated protein kinase kinase 4 (MAP2K4) tumor suppressor gene in ovarian cancer","volume":"11","author":"Davis","year":"2011","journal-title":"BMC Cancer"},{"key":"2026060319584668400_iyag098-B13","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1038\/s41467-024-47271-y","article-title":"Spatial transcriptomics reveals discrete tumour microenvironments and autocrine loops within ovarian cancer subclones","volume":"15","author":"Denisenko","year":"2024","journal-title":"Nat Commun"},{"key":"2026060319584668400_iyag098-B14","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/PGP.0000000000000513","article-title":"Assessment of a chemotherapy response score (CRS) system for tubo-ovarian high-grade serous carcinoma (HGSC)","volume":"38","author":"Ditzel","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"2026060319584668400_iyag098-B15","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/s41467-017-01217-9","article-title":"Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma","volume":"8","author":"Ducie","year":"2017","journal-title":"Nat Commun"},{"key":"2026060319584668400_iyag098-B16","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fcell.2020.00166","article-title":"Modeling cell communication in cancer with organoids: making the complex simple","volume":"8","author":"Fiorini","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"2026060319584668400_iyag098-B17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nature11979","article-title":"Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche","volume":"495","author":"Flesken-Nikitin","year":"2013","journal-title":"Nature"},{"key":"2026060319584668400_iyag098-B18","doi-asserted-by":"publisher","first-page":"8641","DOI":"10.1038\/s41467-024-52984-1","article-title":"Pre-ciliated tubal epithelial cells are prone to initiation of high-grade serous ovarian carcinoma","volume":"15","author":"Flesken-Nikitin","year":"2024","journal-title":"Nat Commun"},{"key":"2026060319584668400_iyag098-B19","first-page":"3459","article-title":"Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium","volume":"63","author":"Flesken-Nikitin","year":"2003","journal-title":"Cancer Res"},{"key":"2026060319584668400_iyag098-B20","doi-asserted-by":"publisher","first-page":"54444","DOI":"10.3791\/54444","article-title":"Transplantation into the mouse ovarian fat pad","volume":"115","author":"Flesken-Nikitin","year":"2016","journal-title":"J Vis Exp"},{"key":"2026060319584668400_iyag098-B21","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1038\/s41588-022-01230-9","article-title":"The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer","volume":"54","author":"Garsed","year":"2022","journal-title":"Nat Genet"},{"key":"2026060319584668400_iyag098-B22","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s42003-025-08065-0","article-title":"The role of IGF2BP3\/SPOP\/c-Myc loop in paclitaxel resistance of endometrial cancer","volume":"8","author":"Ge","year":"2025","journal-title":"Commun Biol"},{"key":"2026060319584668400_iyag098-B23","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1158\/0008-5472.CAN-20-0521","article-title":"Multiomic analysis of subtype evolution and heterogeneity in high-grade serous ovarian carcinoma","volume":"80","author":"Geistlinger","year":"2020","journal-title":"Cancer Res"},{"key":"2026060319584668400_iyag098-B24","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.cell.2014.09.029","article-title":"Genome-scale CRISPR-mediated control of gene repression and activation","volume":"159","author":"Gilbert","year":"2014","journal-title":"Cell"},{"key":"2026060319584668400_iyag098-B25","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.36389","article-title":"The cJUN NH2-terminal kinase (JNK) signaling pathway promotes genome stability and prevents tumor initiation","volume":"7","author":"Girnius","year":"2018","journal-title":"eLife"},{"key":"2026060319584668400_iyag098-B26","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1056\/NEJMoa1910962","article-title":"Niraparib in patients with newly diagnosed advanced ovarian cancer","volume":"381","author":"Gonz\u00e1lez-Mart\u00edn","year":"2019","journal-title":"N Engl J Med"},{"key":"2026060319584668400_iyag098-B27","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.annonc.2023.07.011","article-title":"Newly diagnosed and relapsed epithelial ovarian cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Gonz\u00e1lez-Mart\u00edn","year":"2023","journal-title":"Ann Oncol"},{"key":"2026060319584668400_iyag098-B28","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/gcc.20694","article-title":"Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis","volume":"48","author":"Gorringe","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"2026060319584668400_iyag098-B29","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/ng0296-191","article-title":"Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities","volume":"12","author":"Gowen","year":"1996","journal-title":"Nat Genet"},{"key":"2026060319584668400_iyag098-B30","doi-asserted-by":"publisher","first-page":"10715","DOI":"10.1038\/ncomms10715","article-title":"The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis","volume":"7","author":"Gumireddy","year":"2016","journal-title":"Nat Commun"},{"key":"2026060319584668400_iyag098-B31","doi-asserted-by":"publisher","first-page":"603660","DOI":"10.3389\/fonc.2021.603660","article-title":"FAT3 mutation is associated with tumor mutation burden and poor prognosis in esophageal cancer","volume":"11","author":"Guo","year":"2021","journal-title":"Front Oncol"},{"key":"2026060319584668400_iyag098-B32","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/s0092-8674(00)81302-1","article-title":"The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse","volume":"85","author":"Hakem","year":"1996","journal-title":"Cell"},{"key":"2026060319584668400_iyag098-B33","doi-asserted-by":"publisher","first-page":"22490","DOI":"10.18632\/oncotarget.14989","article-title":"Overlooked FANCD2 variant encodes a promising, portent tumor suppressor, and alternative polyadenylation contributes to its expression","volume":"8","author":"Han","year":"2017","journal-title":"Oncotarget"},{"key":"2026060319584668400_iyag098-B34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13000-019-0781-9","article-title":"High-grade serous ovarian carcinoma with mucinous differentiation: report of a rare and unique case suggesting transition from the \u201cSET\u201d feature of high-grade serous carcinoma to the \u201cSTEM\u201d feature","volume":"14","author":"Hatano","year":"2019","journal-title":"Diagn Pathol"},{"key":"2026060319584668400_iyag098-B35","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3389\/fcell.2020.00647","article-title":"Are epithelial ovarian cancers of the mesenchymal subtype actually intraperitoneal metastases to the ovary?","volume":"8","author":"Hu","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"2026060319584668400_iyag098-B36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2319492121","article-title":"Small-molecule inhibition of MAP2K4 is synergistic with RAS inhibitors in KRAS-mutant cancers","volume":"121","author":"Jansen","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026060319584668400_iyag098-B37","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1038\/nprot.2012.097","article-title":"Primary culture and immortalization of human fallopian tube secretory epithelial cells","volume":"7","author":"Karst","year":"2012","journal-title":"Nat Protoc"},{"key":"2026060319584668400_iyag098-B38","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N Engl J Med"},{"key":"2026060319584668400_iyag098-B39","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1200\/JCO.2007.11.3449","article-title":"Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2","volume":"25","author":"Kauff","year":"2007","journal-title":"J Clin Oncol"},{"key":"2026060319584668400_iyag098-B40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s43046-022-00104-9","article-title":"Subtyping of high grade serous ovarian carcinoma: histopathological and immunohistochemical approach","volume":"34","author":"Khashaba","year":"2022","journal-title":"J Egypt Natl Canc Inst"},{"key":"2026060319584668400_iyag098-B41","doi-asserted-by":"publisher","first-page":"3921","DOI":"10.1073\/pnas.1117135109","article-title":"High-grade serous ovarian cancer arises from fallopian tube in a mouse model","volume":"109","author":"Kim","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026060319584668400_iyag098-B42","doi-asserted-by":"publisher","first-page":"12916","DOI":"10.3390\/ijms222312916","article-title":"Rho-kinase as a target for cancer therapy and its immunotherapeutic potential","volume":"22","author":"Kim","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026060319584668400_iyag098-B43","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/s41591-019-0422-6","article-title":"An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity","volume":"25","author":"Kopper","year":"2019","journal-title":"Nat Med"},{"key":"2026060319584668400_iyag098-B44","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"2026060319584668400_iyag098-B45","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"8","author":"Labidi-Galy","year":"2017","journal-title":"Nat Commun"},{"key":"2026060319584668400_iyag098-B46","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.ccell.2023.04.017","article-title":"Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinoma","volume":"41","author":"Lahtinen","year":"2023","journal-title":"Cancer Cell"},{"key":"2026060319584668400_iyag098-B47","doi-asserted-by":"publisher","first-page":"14498","DOI":"10.1002\/cam4.6102","article-title":"Insights into the leveraging of GABAergic signaling in cancer therapy","volume":"12","author":"Li","year":"2023","journal-title":"Cancer Med"},{"key":"2026060319584668400_iyag098-B48","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3389\/fnins.2018.00563","article-title":"WWOX phosphorylation, signaling, and role in neurodegeneration","volume":"12","author":"Liu","year":"2018","journal-title":"Front Neurosci"},{"key":"2026060319584668400_iyag098-B49","doi-asserted-by":"publisher","first-page":"10697","DOI":"10.18632\/aging.102485","article-title":"MAP2K4 interacts with vimentin to activate the PI3K\/AKT pathway and promotes breast cancer pathogenesis","volume":"11","author":"Liu","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"2026060319584668400_iyag098-B50","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1158\/1535-7163.MCT-22-0004","article-title":"NOTCH signaling limits the response of low-grade serous ovarian cancers to MEK inhibition","volume":"21","author":"Llaurado Fernandez","year":"2022","journal-title":"Mol Cancer Ther"},{"key":"2026060319584668400_iyag098-B51","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1177\/1535370214566747","article-title":"Regulation of cell signaling and apoptosis by tumor suppressor WWOX","volume":"240","author":"Lo","year":"2015","journal-title":"Exp Biol Med (Maywood)"},{"key":"2026060319584668400_iyag098-B52","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1038\/s41467-020-16432-0","article-title":"Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids","volume":"11","author":"L\u00f5hmussaar","year":"2020","journal-title":"Nat Commun"},{"key":"2026060319584668400_iyag098-B53","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.celrep.2019.12.034","article-title":"Mouse ovarian cancer models recapitulate the human tumor microenvironment and patient response to treatment","volume":"30","author":"Maniati","year":"2020","journal-title":"Cell Rep"},{"key":"2026060319584668400_iyag098-B54","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1158\/0008-5472.CAN-19-2558","article-title":"Murine Oviductal high-grade serous carcinomas mirror the genomic alterations, gene expression profiles, and immune microenvironment of their human counterparts","volume":"80","author":"McCool","year":"2020","journal-title":"Cancer Res"},{"key":"2026060319584668400_iyag098-B55","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.1158\/1078-0432.CCR-20-0700","article-title":"First-in-human study of AT13148, a dual ROCK-AKT inhibitor in patients with solid tumors","volume":"26","author":"McLeod","year":"2020","journal-title":"Clin Cancer Res"},{"key":"2026060319584668400_iyag098-B56","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2147\/IJWH.S197604","article-title":"Ovarian cancer in the world: epidemiology and risk factors","volume":"11","author":"Momenimovahed","year":"2019","journal-title":"Int J Womens Health"},{"key":"2026060319584668400_iyag098-B57","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1056\/NEJMoa1810858","article-title":"Maintenance Olaparib in patients with newly diagnosed advanced ovarian cancer","volume":"379","author":"Moore","year":"2018","journal-title":"N Engl J Med"},{"key":"2026060319584668400_iyag098-B58","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/s1097-2765(00)80202-6","article-title":"Brca1 controls homology-directed DNA repair","volume":"4","author":"Moynahan","year":"1999","journal-title":"Mol Cell"},{"key":"2026060319584668400_iyag098-B59","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/s1097-2765(01)00174-5","article-title":"BRCA2 is required for homology-directed repair of chromosomal breaks","volume":"7","author":"Moynahan","year":"2001","journal-title":"Mol Cell"},{"key":"2026060319584668400_iyag098-B60","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.ajpath.2015.12.029","article-title":"Establishment of a novel histopathological classification of high-grade serous ovarian carcinoma correlated with prognostically distinct gene expression subtypes","volume":"186","author":"Murakami","year":"2016","journal-title":"Am J Pathol"},{"key":"2026060319584668400_iyag098-B61","doi-asserted-by":"publisher","first-page":"630","DOI":"10.4161\/cbt.5.6.2675","article-title":"Homozygous deletion of MKK4 in ovarian serous carcinoma","volume":"5","author":"Nakayama","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"2026060319584668400_iyag098-B62","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nature14410","article-title":"Whole-genome characterization of chemoresistant ovarian cancer","volume":"521","author":"Patch","year":"2015","journal-title":"Nature"},{"key":"2026060319584668400_iyag098-B63","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.ygyno.2015.09.018","article-title":"Clinical outcomes in patients with isolated serous tubal intraepithelial carcinoma (STIC): a comprehensive review","volume":"139","author":"Patrono","year":"2015","journal-title":"Gynecol Oncol"},{"key":"2026060319584668400_iyag098-B64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102289","article-title":"Mitogen-activated protein kinase kinase 4 (MAP2K4) promotes human prostate cancer metastasis","volume":"9","author":"Pavese","year":"2014","journal-title":"PLoS One"},{"key":"2026060319584668400_iyag098-B65","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models","volume":"24","author":"Perets","year":"2013","journal-title":"Cancer Cell"},{"key":"2026060319584668400_iyag098-B66","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3390\/cancers17040604","article-title":"Aggressive serous carcinomas of the female reproductive tract: cancer-prone cell states and genetic drivers","volume":"17","author":"Phuong","year":"2025","journal-title":"Cancers (Basel)"},{"key":"2026060319584668400_iyag098-B67","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/nature14221","article-title":"Cell-of-origin chromatin organization shapes the mutational landscape of cancer","volume":"518","author":"Polak","year":"2015","journal-title":"Nature"},{"key":"2026060319584668400_iyag098-B68","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ygyno.2013.01.029","article-title":"Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy","volume":"129","author":"Powell","year":"2013","journal-title":"Gynecol Oncol"},{"key":"2026060319584668400_iyag098-B69","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-2407-8-17","article-title":"Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities","volume":"8","author":"Press","year":"2008","journal-title":"BMC Cancer"},{"key":"2026060319584668400_iyag098-B70","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00404-010-1476-3","article-title":"Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers","volume":"283","author":"Rhiem","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"2026060319584668400_iyag098-B71","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ygyno.2021.08.021","article-title":"Efficacy of risk-reducing salpingo-oophorectomy in BRCA1-2 variants and clinical outcomes of follow-up in patients with isolated serous tubal intraepithelial carcinoma (STIC)","volume":"163","author":"Saccardi","year":"2021","journal-title":"Gynecol Oncol"},{"key":"2026060319584668400_iyag098-B72","doi-asserted-by":"publisher","first-page":"15818","DOI":"10.18632\/oncotarget.24530","article-title":"WT1, p53 and p16 expression in the diagnosis of low- and high-grade serous ovarian carcinomas and their relation to prognosis","volume":"9","author":"Sallum","year":"2018","journal-title":"Oncotarget"},{"key":"2026060319584668400_iyag098-B73","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.cell.2011.03.041","article-title":"Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11","volume":"145","author":"Schlacher","year":"2011","journal-title":"Cell"},{"key":"2026060319584668400_iyag098-B74","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ccr.2012.05.015","article-title":"A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1\/2","volume":"22","author":"Schlacher","year":"2012","journal-title":"Cancer Cell"},{"key":"2026060319584668400_iyag098-B75","doi-asserted-by":"publisher","first-page":"14726","DOI":"10.1038\/s41598-022-19029-3","article-title":"Fat3 regulates neural progenitor cells by promoting Yap activity during spinal cord development","volume":"12","author":"Seo","year":"2022","journal-title":"Sci Rep"},{"key":"2026060319584668400_iyag098-B76","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ajpath.2020.09.006","article-title":"The origin of ovarian cancer species and precancerous landscape","volume":"191","author":"Shih","year":"2021","journal-title":"Am J Pathol"},{"key":"2026060319584668400_iyag098-B77","doi-asserted-by":"publisher","first-page":"12742","DOI":"10.1038\/s41598-023-39608-2","article-title":"Mutational landscape of cancer-driver genes across human cancers","volume":"13","author":"Sinkala","year":"2023","journal-title":"Sci Rep"},{"key":"2026060319584668400_iyag098-B78","doi-asserted-by":"publisher","first-page":"508.e1","DOI":"10.1016\/j.ajog.2021.06.070","article-title":"Uptake and timing of risk-reducing salpingo-oophorectomy among patients with BRCA1 and BRCA2 mutations","volume":"225","author":"Smith","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"2026060319584668400_iyag098-B79","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.ygyno.2006.12.017","article-title":"Regulation of the metastasis suppressor gene MKK4 in ovarian cancer","volume":"105","author":"Spillman","year":"2007","journal-title":"Gynecol Oncol"},{"key":"2026060319584668400_iyag098-B80","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1101\/gad.11.10.1242","article-title":"Brca2 is required for embryonic cellular proliferation in the mouse","volume":"11","author":"Suzuki","year":"1997","journal-title":"Genes Dev"},{"key":"2026060319584668400_iyag098-B81","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.170423","volume-title":"Evolutionary mode and timing of dissemination of high-grade serous carcinomas","author":"Sveen","year":"2024"},{"key":"2026060319584668400_iyag098-B82","first-page":"4177","article-title":"Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor","volume":"57","author":"Teng","year":"1997","journal-title":"Cancer Res"},{"key":"2026060319584668400_iyag098-B83","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1101\/gad.851000","article-title":"Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress","volume":"14","author":"Tibbetts","year":"2000","journal-title":"Genes Dev"},{"key":"2026060319584668400_iyag098-B84","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1177\/1947601913486349","article-title":"The 2 faces of JNK signaling in cancer","volume":"4","author":"Tournier","year":"2013","journal-title":"Genes Cancer"},{"key":"2026060319584668400_iyag098-B85","doi-asserted-by":"publisher","first-page":"240","DOI":"10.5146\/tjpath.2022.01571","article-title":"Evidence for diverse prognosis in high-grade serous ovarian carcinoma: solid, pseudoendometrioid, and transitional-like; so-called \u201cSET morphology\u201d and progesterone receptor Status","volume":"38","author":"Uner","year":"2022","journal-title":"Turk Patoloji Derg"},{"key":"2026060319584668400_iyag098-B86","doi-asserted-by":"publisher","first-page":"4513","DOI":"10.1038\/s41598-022-08503-7","article-title":"Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy","volume":"12","author":"Uno","year":"2022","journal-title":"Sci Rep"},{"key":"2026060319584668400_iyag098-B87","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1172\/JCI65833","article-title":"Prognostically relevant gene signatures of high-grade serous ovarian carcinoma","volume":"123","author":"Verhaak","year":"2013","journal-title":"J Clin Invest"},{"key":"2026060319584668400_iyag098-B88","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.10414","article-title":"Classification of ovarian cancer associated with BRCA1 mutations, immune checkpoints, and tumor microenvironment based on immunogenomic profiling","volume":"8","author":"Wei","year":"2020","journal-title":"PeerJ"},{"key":"2026060319584668400_iyag098-B89","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1080\/14737140.2016.1247699","article-title":"Serous tubal intraepithelial carcinoma (STIC)\u2014clinical impact and management","volume":"16","author":"Weinberger","year":"2016","journal-title":"Expert Rev Anticancer Ther"},{"key":"2026060319584668400_iyag098-B90","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s001090050063","article-title":"Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways","volume":"74","author":"Whitmarsh","year":"1996","journal-title":"J"},{"key":"2026060319584668400_iyag098-B91","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41422-018-0044-4","article-title":"MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer models","volume":"28","author":"Xue","year":"2018","journal-title":"Cell Res"},{"key":"2026060319584668400_iyag098-B92","first-page":"6717","article-title":"Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma","volume":"62","author":"Yamada","year":"2002","journal-title":"Cancer Res"},{"key":"2026060319584668400_iyag098-B93","doi-asserted-by":"publisher","first-page":"108086","DOI":"10.1016\/j.celrep.2020.108086","article-title":"Most commonly mutated genes in high-grade serous ovarian carcinoma are nonessential for ovarian surface epithelial stem cell transformation","volume":"32","author":"Yamulla","year":"2020","journal-title":"Cell Rep"},{"key":"2026060319584668400_iyag098-B94","doi-asserted-by":"publisher","first-page":"5072","DOI":"10.1158\/1078-0432.CCR-18-0504","article-title":"Paclitaxel sensitivity of ovarian cancer can be enhanced by knocking down pairs of kinases that regulate MAP4 phosphorylation and microtubule stability","volume":"24","author":"Yang","year":"2018","journal-title":"Clin Cancer Res"},{"key":"2026060319584668400_iyag098-B95","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13073-018-0590-x","article-title":"Landscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivors","volume":"10","author":"Yang","year":"2018","journal-title":"Genome Med"},{"key":"2026060319584668400_iyag098-B96","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s13277-011-0166-5","article-title":"MKK4 acts as a potential tumor suppressor in ovarian cancer","volume":"32","author":"Yeasmin","year":"2011","journal-title":"Tumour Biol"},{"key":"2026060319584668400_iyag098-B97","doi-asserted-by":"publisher","first-page":"110146","DOI":"10.1016\/j.celrep.2021.110146","article-title":"Human iPSC-derived fallopian tube organoids with BRCA1 mutation recapitulate early-stage carcinogenesis","volume":"37","author":"Yucer","year":"2021","journal-title":"Cell Rep"},{"key":"2026060319584668400_iyag098-B98","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/path.4927","article-title":"High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease","volume":"243","author":"Zhai","year":"2017","journal-title":"J Pathol"},{"key":"2026060319584668400_iyag098-B99","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1038\/s41467-019-13116-2","article-title":"Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat Commun"},{"key":"2026060319584668400_iyag098-B100","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1158\/2159-8290.CD-20-0455","article-title":"Genetically defined, syngeneic organoid platform for developing combination therapies for ovarian cancer","volume":"11","author":"Zhang","year":"2021","journal-title":"Cancer Discov"},{"key":"2026060319584668400_iyag098-B101","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1111\/jcmm.14830","article-title":"Identification of immune-enhanced molecular subtype associated with BRCA1 mutations, immune checkpoints and clinical outcome in ovarian carcinoma","volume":"24","author":"Zheng","year":"2020","journal-title":"J Cell Mol Med"}],"container-title":["GENETICS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/genetics\/advance-article-pdf\/doi\/10.1093\/genetics\/iyag098\/68088876\/iyag098.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/genetics\/article-pdf\/233\/2\/iyag098\/68088876\/iyag098.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/genetics\/article-pdf\/233\/2\/iyag098\/68088876\/iyag098.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T23:58:54Z","timestamp":1780531134000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/genetics\/article\/doi\/10.1093\/genetics\/iyag098\/8654679"}},"subtitle":[],"editor":[{"given":"S","family":"Lacefield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":101,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4,15]]},"published-print":{"date-parts":[[2026,6,3]]}},"URL":"https:\/\/doi.org\/10.1093\/genetics\/iyag098","relation":{},"ISSN":["1943-2631"],"issn-type":[{"value":"1943-2631","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,4,15]]},"article-number":"iyag098"}}